EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
The end of US clouds in Europe?
-
How should Europe riposte to the Trump tariff wars? I visited with some
friends in Madrid recently.
I was surprised how quickly the consensus was rea...
2 days ago
No comments:
Post a Comment